Home About us Contact
|
Home About us Contact | ||
|
|
||
Lower Organisms (lower + organism)
Selected AbstractsThree-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2ACTA CRYSTALLOGRAPHICA SECTION D, Issue 12 2003Eugenia Pechkova The three-dimensional crystal structure of the triple-point mutant of the catalytic subunit of human protein kinase CK2, has been determined at 2.4,Å resolution. Microcrystals of mutant CK2 catalytic subunit were obtained by a protein-crystallization method based on thin-film nanotechnology. These microcrystals (of about 20,µm in diameter) were used for diffraction data collection by means of the microfocus beamline at the ESRF synchrotron. A comparison between the human protein kinase CK2, and the corresponding enzyme from a lower organism (Zea mays) is made. [source] Protease,proteoglycan complexes of mouse and human mast cells and importance of their ,-tryptase,heparin complexes in inflammation and innate immunityIMMUNOLOGICAL REVIEWS, Issue 1 2007Richard L. Stevens Summary:, Approximately 50% of the weight of a mature mast cell (MC) consists of varied neutral proteases stored in the cell's secretory granules ionically bound to serglycin proteoglycans that contain heparin and/or chondroitin sulfate E/diB chains. Mouse MCs express the exopeptidase carboxypeptidase A3 and at least 15 serine proteases [designated as mouse MC protease (mMCP) 1,11, transmembrane tryptase/tryptase ,/protease serine member S (Prss) 31, cathepsin G, granzyme B, and neuropsin/Prss19]. mMCP-6, mMCP-7, mMCP-11/Prss34, and Prss31 are the four members of the chromosome 17A3.3 family of tryptases that are preferentially expressed in MCs. One of the challenges ahead is to understand why MCs express so many different protease,proteoglycan macromolecular complexes. MC-like cells that contain tryptase,heparin complexes in their secretory granules have been identified in the Ciona intestinalis and Styela plicata urochordates that appeared approximately 500 million years ago. Because sea squirts lack B cells and T cells, it is likely that MCs and their tryptase,proteoglycan granule mediators initially appeared in lower organisms as part of their innate immune system. The conservation of MCs throughout evolution suggests that some of these protease,proteoglycan complexes are essential to our survival. In support of this conclusion, no human has been identified that lacks MCs. Moreover, transgenic mice lacking the ,-tryptase mMCP-6 are unable to combat a Klebsiella pneumoniae infection effectively. Here we summarize the nature and function of some of the tryptase,serglycin proteoglycan complexes found in mouse and human MCs. [source] The uptake of applied ecologyJOURNAL OF APPLIED ECOLOGY, Issue 1 2002S. J. Ormerod Summary 1We asked 229 authors who have published recently in the Journal of Applied Ecology (1999,2001) whether their papers made management or policy recommendations and whether they had evidence of consequent uptake. 2A total of 108 respondents working in the UK (34%), Europe (30%), the Americas (12%), Australasia (11%), Asia (7%) and Africa (6%) reported on 110 papers. They represented agro-ecosystems (35%), temperate forests or woodlands (16%), savanna, grass or arid lands (11%), rivers or wetlands (10%), estuaries or marine systems (7%) and tropical forests (5%). The major organisms were invertebrates (27%), birds (24%), mammals (21%) and higher plants (21%). Topics apparently under-represented in recent coverage include ecosystem science, urban areas, soils, mountain systems, fish, amphibians and lower organisms such as algae. 3Almost all papers (99%) carried recommendations and for 57% there was evidence of uptake in the broad categories of ,environmental management or models', ,information, training and education' and ,monitoring and assessment'. Most uptake involved large geographical scales through habitat or species management plans (32% of cases), effects on reserve design or designation (6%), and effects on agri-environmental policy (5%). The development of further research (11%), the communication of methods to other ecologists (9%), the dissemination of recommendations to practitioners or agencies (7%), and uptake in training or education (5%) were important uses of information. 4Prestige from publication in the Journal of Applied Ecology aided several authors in convincing end-users of research value. User involvement in research as participants or funders was widespread (> 42% of papers), a fact which almost certainly promotes uptake along with the parallel dissemination of management messages. We view applied issues as an important interface between end-users and ecologists of value to ,both' communities but suggest that improved communication will further benefit the sponsorship and application of ecological science. 5The major reason offered for lack of uptake was that it was still too soon after publication (21% of respondents). Costs, difficulty of implementation, the scale of the problem, and ,challenges to existing thinking' each figured in more than one response. 6For some respondents, papers were led by curiosity rather than the need for direct application. Several authors published in the Journal to share ideas internationally, or said that recommendations were general, conceptual or long-term rather than specific. The editors of the Journal of Applied Ecology recognize the seminal importance of contributions that affect policy incrementally and conceptually as much as those with specific application. 7These data provide evidence that ecological science is aiding environmental management and policy across a wide range of regions, ecosystems and types of organisms; rather than merely detecting problems, applied ecology is offering solutions both directly and more diffusely through conceptual advance. We invite the user community to offer their own perspectives about the value of research-led publications such as this Journal, about how links between researchers and users might be strengthened, and about how the uptake of applied ecology might be further advanced. [source] Evaluation of the antimicrobial activity of ebselen: Role of the yeast plasma membrane H+ -ATPaseJOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, Issue 5 2007Grace Chan Abstract Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is a selenium-containing antioxidant demonstrating anti-inflammatory and cytoprotective properties in mammalian cells and cytotoxicity in lower organisms. The mechanism underlying the antimicrobial activity of ebselen remains unclear. It has recently been proposed that, in lower organisms like yeast, the plasma membrane H+ -ATPase (Pma1p) could serve as a potential target for this synthetic organoselenium compound. Using yeast and bacteria, the present study found ebselen to inhibit microbial growth in a concentration- and time-dependent manner, and yeast and Gram-positive bacteria to be more sensitive to this action (IC50 , 2,5 ,M) than Gram-negative bacteria (IC50 < 80 ,M). Washout experiments and scanning electron microscopic analysis revealed ebselen to possess fungicidal activity. In addition, ebselen was found to inhibit medium acidification by PMA1 -proficient haploid yeast in a concentration-dependent manner. Additional studies comparing PMA1 (+/,) and PMA1 (+/+) diploid yeast cells revealed the mutant to be more sensitive to treatment with ebselen than the wild type. Ebselen also inhibited the ATPase activity of Pma1p from S. cerevisae in a concentration-dependent manner. The interaction of ebselen with the sulfhydryl-containing compounds L -cysteine and reduced glutathione resulted in the complete and partial prevention, respectively, of the inhibition of Pma1p ATPase activity by ebselen. Taken together, these results suggest that the fungicidal action of ebselen is due, at least in part, to interference with both the proton-translocating function and the ATPase activity of the plasma membrane H+ -ATPase. © 2007 Wiley Periodicals, Inc. J Biochem Mol Toxicol 21:252,264, 2007; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20189 [source] Aging and disease: connections to sirtuinsAGING CELL, Issue 2 2010Gizem Donmez Summary The sirtuins are highly conserved NAD-dependent deacetylases that were shown to regulate lifespan in lower organisms and affect diseases of aging in mammals, such as diabetes, cancer, and inflammation. Most relevant to the amelioration of disease, the SIR2 ortholog SIRT1 has been shown to deacetylate many important transcription factors to exert an overarching influence on numerous metabolic pathways. Here we discuss several diseases of aging for which SIRT1 has been recently shown to confer protection. These findings suggest that manipulating sirtuin activity pharmacologically may be a fruitful area to improve human health. [source] Neuronal protection by sirtuins in Alzheimer's diseaseJOURNAL OF NEUROCHEMISTRY, Issue 2 2006Thimmappa S. Anekonda Abstract Silent information regulator 2, a member of NAD+ -dependent histone deacetylase in yeast, and its homologs in mice and humans, participate in numerous important cell functions, including cell protection and cell cycle regulation. The sirtuin family members are highly conserved evolutionarily, and are predicted to have a role in cell survival. The science of sirtuins is an emerging field and is expected to contribute significantly to the role of sirtuins in healthy aging in humans. The role of sirtuins in neuronal protection has been studied in lower organisms, such as yeast, worms, flies and rodents. Both yeast Sir2 and mammalian sirtuin proteins are up-regulated under calorie-restricted and resveratrol treatments. Increased sirtuin expression protects cells from various insults. Caloric restriction and antioxidant treatments have shown useful effects in mouse models of aging and Alzheimer's disease (AD) and in limited human AD clinical trials. The role sirtuins may play in modifying and protecting neurons in patients with neurodegenerative diseases is still unknown. However, a recent report of Huntington's disease revealed that Sirtuin protects neurons in a Huntington's disease mouse model, suggesting that sirtuins may protect neurons in patients with neurodegenerative diseases, such as AD. In this review, we discuss the possible mechanisms of sirtuins involved in neuronal protection and the potential therapeutic value of sirtuins in healthy aging and AD. [source] | |||||||||||||